Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Medilink Therapeutics Announces Global License Agreement and Strategic Collaboration With Biontech for Advancing Next-generation Anti-cancer Antibody-drug Conjugates
Friday, October 13, 2023MediLink Therapeutics referred to as MediLink announced today a strategic research partnership and global licensing agreement with BioNTech SE
Fujitsu and RIKEN Develop AI Technology for Predicting Protein Structural Changes
Thursday, October 12, 2023Fujitsu and RIKEN have jointly unveiled an AIdriven drug discovery technology capable of predicting structural changes in proteins using generative AI technology which converts electron microscope images into D density maps
Immetas and GC Biopharma Collaborate on mRNA Therapeutics for Autoimmune Diseases
Thursday, October 12, 2023Immetas Therapeutics and GC Biopharma have entered into a research collaboration to develop novel mRNA therapeutics for the treatment of autoimmune diseases
Astellas Pharma, BioLabs, and Mitsui Fudosan Collaborate to Enhance Life Science Ecosystems in Japan
Wednesday, October 11, 2023Astellas BioLabs and Mitsui Fudosan have jointly established a memorandum of understanding to enhance the life science ecosystem in Japan
Monash University Partners with Orio Therapeutics to Transform Regenerative Medicine
Tuesday, October 10, 2023Monash University teams up with Orio Therapeutics in hybrid equity and licencing deal to revolutionise regenerative medicine through novel drug delivery technology
Belite Bio Submits Tinlarebant Phase 3 GA Clinical Trial Application to Swissmedic
Saturday, October 07, 2023Belite Bio has announced its submission to Swissmedic for the initiation of the Phase clinical trial of Tinlarebant known as the PHOENIX study in Switzerland
BiomX Completes Patient Dosing in Phase 1b/2a Study for BX004 in Cystic Fibrosis
Friday, October 06, 2023BiomX has announced the successful completion of patient dosing in the second part of its phase ba clinical trial assessing BX a novel treatment aimed at addressing chronic pulmonary infections resulting from Pseudomonas aeruginosa in individuals d...
Kyowa Kirin Announces Acquisition of Orchard Therapeutics
Friday, October 06, 2023This acquisition will enable Kyowa Kirin to enhance the value of Libmeldy and expedite the advancement of Orchard Therapeutics nextinline MPS programmes as well as its early research initiatives including genetic Crohns disease and frontotemporal dem...
GC Biopharma Announces FDA Orphan Drug Designation for GC1126A
Friday, October 06, 2023GC Biopharma announced that GCA a drug candidate for thrombotic thrombocytopenic purpura TTP has received orphan drug designation from the US Food and Drug Administration FDA
PharmaEssentia Enters into Global Licence Agreement with WuXi Biologics
Wednesday, October 04, 2023PharmaEssentia has signed a significant licence agreement with WuXi Biologics securing exclusive global rights for the research development manufacturing and commercialisation of a promising myeloid immune checkpoint antibody candidate
